Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, 1160 West Michigan Street, Indianapolis, IN 46202-5209, USA.
Stark Neuroscience Research Institute, 320 West 15th Street, Indianapolis, IN 46202-2266, USA.
Cells. 2021 Oct 24;10(11):2864. doi: 10.3390/cells10112864.
The homeostasis of extracellular matrix (ECM) and actin dynamics in the trabecular meshwork (TM) outflow pathway plays a critical role in intraocular pressure (IOP) regulation. We studied the role of cathepsin K (CTSK), a lysosomal cysteine protease and a potent collagenase, on ECM modulation and actin cytoskeleton rearrangements in the TM outflow pathway and the regulation of IOP. Initially, we found that CTSK was negatively regulated by pathological stressors known to elevate IOP. Further, inactivating CTSK using balicatib, a pharmacological cell-permeable inhibitor of CTSK, resulted in IOP elevation due to increased levels and excessive deposition of ECM-like collagen-1A in the TM outflow pathway. The loss of CTSK activity resulted in actin-bundling via fascin and vinculin reorganization and by inhibiting actin depolymerization via phospho-cofilin. Contrarily, constitutive expression of CTSK decreased ECM and increased actin depolymerization by decreasing phospho-cofilin, negatively regulated the availability of active TGFβ2, and reduced the levels of alpha-smooth muscle actin (αSMA), indicating an antifibrotic action of CTSK. In conclusion, these observations, for the first time, demonstrate the significance of CTSK in IOP regulation by maintaining the ECM homeostasis and actin cytoskeleton-mediated contractile properties of the TM outflow pathway.
细胞外基质 (ECM) 的动态平衡和小梁网 (TM) 流出道中的肌动蛋白动力学在眼压 (IOP) 调节中起着关键作用。我们研究了组织蛋白酶 K (CTSK) 在 ECM 调节和 TM 流出道中肌动蛋白细胞骨架重排以及 IOP 调节中的作用。最初,我们发现 CTSK 受到已知会升高 IOP 的病理应激的负调控。此外,使用巴立替尼(一种细胞通透性的 CTSK 药理学抑制剂)使 CTSK 失活会导致 IOP 升高,原因是 TM 流出道中 ECM 样胶原 1A 的水平升高和过度沉积。CTSK 活性的丧失会导致肌动蛋白束通过 fascin 和 vinculin 的重排而聚集,并通过抑制肌动蛋白解聚来抑制 phospho-cofilin。相反,CTSK 的组成性表达通过降低 phospho-cofilin 来减少 ECM 并增加肌动蛋白解聚,负调控活性 TGFβ2 的可用性,并降低α-平滑肌肌动蛋白 (αSMA) 的水平,表明 CTSK 具有抗纤维化作用。总之,这些观察结果首次证明了 CTSK 在维持 ECM 动态平衡和 TM 流出道肌动蛋白细胞骨架介导的收缩特性方面在 IOP 调节中的重要性。